NYSE$NHI
National Health Investors Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Announced second quarter 2022 results, impacted by Bickford's conversion to cash basis accounting but otherwise in line with expectations.
National Health Investors, Inc. reported second quarter results with net income attributable to common stockholders per diluted common share at $0.47. The company completed disposition of 10 underperforming senior housing properties and repurchased approximately 1.2 million shares. They reduced debt by approximately $145.0 million and reported net debt to Adjusted EBITDA of 4.0x.
- Converted Bickford Senior Living to the cash basis of accounting, writing off $18.1 million of straight-line rents receivable and $7.1 million of lease incentives.
- Settled litigation against Welltower, receiving $6.9 million and terminating the master lease for 17 legacy Holiday independent living facilities.
- Formed a new Seniors Housing Operating Portfolio (SHOP) segment, contributing approximately $2.9 million to NHI’s net operating income.
- Completed the disposition of 10 underperforming senior housing properties for net proceeds of approximately $76.3 million.
Headline financials
Revenue & EPS history
NHI · Revenue · Quarterly
$59.9M
Revenue by segment
NHI · $68.4M total across 1 segment · Q2 2021
- Rental income$68.4M—100.0%
Forward guidance
NHI updated its range for 2022 annual guidance, originally issued on April 18, 2022.
Tailwinds
- NAREIT FFO per diluted common share in a range of $3.86 - $3.92
- Normalized FFO per diluted common share in a range of $4.48 - $4.53
- Normalized Funds Available for Distribution in a range of $200.2 million - $203.0 million
- Weighted average diluted common shares of 45.2 million
Headwinds
- Continued rent concessions throughout 2022
- Asset dispositions throughout 2022
- Loan repayments throughout 2022
- Approximately $52.6 million in investment funding of existing commitments
- No incremental benefit from unidentified acquisitions or repayment of outstanding deferral balances.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+0.1%
Avg return
Earnings day
+0.6%
Avg return
5 days after
+1.3%
Avg return
30 days after
59%
40 / 68 earnings
Positive
+14.9%
Q3 2020
Best reaction
-7.9%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.4% | -1.9% | -9.4% | |
| Q4 2025 | -4.2% | -3.2% | -6.3% | |
| Q3 2025 | +1.8% | +1.1% | +4.1% | |
| Q1 2025 | +0.5% | +1.0% | -6.2% | |
| Q4 2024 | -0.2% | +2.9% | +4.8% | |
| Q3 2024 | +1.1% | +7.0% | -0.4% | |
| Q2 2024 | +3.0% | +3.2% | +13.8% | |
| Q1 2024 | +1.4% | +0.9% | +2.8% | |
| Q4 2023 | +6.6% | +8.4% | +16.5% | |
| Q3 2023 | +0.5% | -0.7% | +7.8% | |
| Q2 2023 | -7.5% | -6.7% | -9.4% | |
| Q1 2023 | +7.6% | +8.3% | +8.0% | |
| Q4 2022 | -7.9% | -6.5% | -17.5% | |
| Q3 2022 | -1.4% | +3.4% | +2.1% | |
| Q2 2022 | +2.6% | +4.9% | +4.5% | |
| Q1 2022 | -3.4% | +1.4% | +12.8% | |
| Q4 2021 | -3.2% | -2.0% | +6.4% | |
| Q3 2021 | +1.4% | +1.8% | +1.4% | |
| Q2 2021 | -6.2% | -5.5% | -9.7% | |
| Q1 2021 | -3.1% | -4.9% | -5.6% | |
| Q4 2020 | -0.6% | +0.1% | +7.5% | |
| Q3 2020 | +14.9% | +18.0% | +20.7% | |
| Q2 2020 | +0.1% | -2.8% | -1.0% | |
| Q1 2020 | -4.2% | -11.3% | +19.2% | |
| Q4 2019 | +1.4% | +1.8% | -57.5% | |
| Q3 2019 | -2.0% | -2.0% | +1.0% | |
| Q2 2019 | +2.1% | +2.0% | +3.9% | |
| Q1 2019 | -1.2% | +0.8% | +3.4% | |
| Q4 2018 | -6.9% | -4.0% | -5.7% | |
| Q3 2018 | +1.6% | +2.4% | +8.0% | |
| Q2 2018 | +1.0% | +0.1% | +3.1% | |
| Q1 2018 | +1.9% | +1.7% | +6.7% | |
| Q4 2017 | +0.0% | +0.8% | +7.5% | |
| Q3 2017 | -2.9% | -1.5% | -0.6% | |
| Q2 2017 | +1.0% | +2.8% | +6.7% | |
| Q1 2017 | +2.5% | +4.4% | +5.1% | |
| Q4 2016 | +0.7% | +1.1% | -3.9% | |
| Q3 2016 | -0.3% | -5.5% | +1.1% | |
| Q2 2016 | +0.6% | +2.0% | +3.4% | |
| Q1 2016 | +1.9% | — | — | |
| Q4 2015 | +3.8% | — | — | |
| Q3 2015 | -0.1% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | +1.5% | — | — | |
| Q4 2014 | +0.4% | — | — | |
| Q3 2014 | -0.7% | — | — | |
| Q2 2014 | +2.6% | — | — | |
| Q1 2014 | +1.5% | — | — | |
| Q4 2013 | -1.0% | — | — | |
| Q3 2013 | -0.7% | — | — | |
| Q2 2013 | -0.0% | — | — | |
| Q1 2013 | +3.3% | — | — | |
| Q4 2012 | -1.1% | — | — | |
| Q3 2012 | +1.3% | — | — | |
| Q2 2012 | -2.7% | — | — | |
| Q1 2012 | +1.2% | — | — | |
| Q4 2011 | -2.4% | — | — | |
| Q3 2011 | +0.8% | — | — | |
| Q2 2011 | -5.4% | — | — | |
| Q1 2010 | -2.5% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q4 2008 | +0.2% | — | — | |
| Q4 2010 | +0.2% | — | — | |
| Q3 2010 | +1.6% | — | — | |
| Q3 2009 | +1.6% | — | — | |
| Q2 2010 | +0.9% | — | — | |
| Q2 2009 | +0.9% | — | — | |
| Q4 2009 | +0.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro